Results 121 to 130 of about 77,126 (266)

Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock.

open access: yesPLoS ONE, 2019
IntroductionThe prevalence of hypoalbuminemia, early changes of plasma albumin (P-Alb) levels, and their effects on mortality in cardiogenic shock are unknown.Materials and methodsP-Alb was measured from serial blood samples in 178 patients from a ...
Toni Jäntti   +16 more
doaj   +1 more source

The hypothalamic-pituitary-adrenal axis in critical illness [PDF]

open access: yes, 1993
Plasma ACTH and cortisol concentrations are frequently elevated in patients in intensive care units (ICU). To examine the functional integrity of the hypothalamic-pituitary-adrenal axis during critical illness, we evaluated prospectively 53 ICU patients ...
Allolio, B.   +3 more
core  

Clinical phenotyping of cardiogenic shock at a glance: A rapid, costless, streamlined approach

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Cardiogenic shock (CS) is a heterogeneous syndrome in which recent guidelines have proposed clinical phenotyping based on the presence of hypoperfusion and/or congestion signs and symptoms. However, the impact of this clinical phenotype on outcomes remains poorly characterized.
Miloud Cherbi   +5 more
wiley   +1 more source

Proteins associated with rehospitalization, mortality and diuretic resistance in acutely decompensated heart failure

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Most proteomic analyses in patients with heart failure (HF) focus on the stable ambulatory setting; pathways that drive acute decompensated heart failure (ADHF) are largely uncharacterized. We aimed to examine the associations of cardiometabolic proteins with HF rehospitalization, mortality and diuretic response in patients with ADHF ...
Kenneth T. Hubbell   +8 more
wiley   +1 more source

Stress induced cardiomyopathy complicated by cardiogenic shock: A non-survivor case

open access: yesEgyptian Journal of Critical Care Medicine, 2018
Stress induced cardiomyopathy complicated by refractory cardiogenic shock is challenging as treatment by inotropes and vasopressors may be ineffective.
M. Abouelwafa   +8 more
doaj  

Clinical impact of follow‐up endomyocardial biopsy in myocarditis during or after immune‐suppressive therapy

open access: yesESC Heart Failure, EarlyView.
Results and clinical implication of repeat endomyocardial biopsy (EMB). Abstract Aims While the diagnostic role of endomyocardial biopsy (EMB) in myocarditis is unquestioned, little is known about its indications and clinical value during long‐term follow‐up.
Anna Baritussio   +12 more
wiley   +1 more source

Analysis of outcomes in patients with HeartMate 3 with and without right ventricular assist device support

open access: yesESC Heart Failure, EarlyView.
Temporary RVAD support following HM3 LVAD is associated with high morbidity and mortality. Temporary RVAD support occurs most frequently in INTERMACS 1 or 2 patients and those who require pre‐operative VA‐ECMO. In addition to higher post‐operative mortality, a significantly higher risk of both dialysis and stroke at 1 year post‐implant was observed in ...
Vinh Q. Chau   +12 more
wiley   +1 more source

Intra-aortic balloon pump in cardiogenic shock: state of the art

open access: yesRevista do Colégio Brasileiro de Cirurgiões
The clinical definition of cardiogenic shock is that of a low cardiac output and evidence of tissue hypoxia in the presence of adequate blood volume.
PETRONIO GENEROSO THOMAZ   +3 more
doaj   +1 more source

Angiotensin receptor‐neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Angiotensin receptor‐neprilysin inhibitor (ARNI) therapy has demonstrated improved outcomes in heart failure with reduced ejection fraction (HFrEF). However, its benefits in patients with concomitant kidney failure undergoing replacement therapy remain uncertain. Methods and results Using the National Health Insurance Service database, we
Mi‐Hyang Jung   +8 more
wiley   +1 more source

Clinical impact of tricuspid regurgitation in patients with acute myocardial infarction

open access: yesESC Heart Failure, EarlyView.
Abstract Aims The clinical impact of tricuspid regurgitation (TR) in patients after acute myocardial infarction (AMI) is largely unknown. The aim of this study was to clarify the prevalence and prognostic impact of TR in post‐AMI patients treated with appropriate primary percutaneous coronary intervention (PCI).
Shun Nishino   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy